Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma × Prednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma 42 Precursor Cell Lymphoblastic Leukemia-Lymphoma 32 Prostatic Neoplasms 28 Lymphoma, Large B-Cell, Diffuse 28 Lymphoma, Follicular 15 Leukemia 15 Lymphoma, Non-Hodgkin 12 Hodgkin Disease 11 Burkitt Lymphoma 10 Leukemia, Biphenotypic, Acute 8 Recurrence 6 Neoplasms 6 Neoplasm Metastasis 6 Lymphoma, Large-Cell, Anaplastic 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, B-Cell 5 Ovarian Neoplasms 4 Multiple Myeloma 4 Immunoblastic Lymphadenopathy 4 Hemangioma 4 Dendritic Cell Sarcoma, Interdigitating 4 Lymphoma, T-Cell, Peripheral 3 Lymphoma, T-Cell 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, B-Cell, Marginal Zone 3 Breast Neoplasms 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Neurotoxicity Syndromes 2 Neoplasm, Residual 2

Interventions

Cisplatin 55 Carboplatin 48 Paclitaxel 42 pembrolizumab 41 Gemcitabine 28 Pemetrexed 22 Radiotherapy 21 Magnetic Resonance Spectroscopy 20 Radiotherapy, Intensity-Modulated 18 Docetaxel 17 Cetuximab 17 Specimen Handling 16 Nivolumab 16 Fluorouracil 16 Cyclophosphamide 14 durvalumab 13 Bevacizumab 12 Radiation 11 Sorafenib 10 Platinum 10 130-nm albumin-bound paclitaxel 10 1,2-diaminocyclohexaneplatinum II citrate 10 osimertinib 9 Sunitinib 8 Oxaliplatin 8 Irinotecan 8 Everolimus 8 Drug Therapy 8 Capecitabine 8 atezolizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00822809 2012-10-03

CASIMAS

Neovii Biotech

Phase 3 Completed

Carcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡